Control of food intake and muscle wasting in cachexia

被引:51
作者
Amitani, Marie [1 ]
Asakawa, Akihiro [1 ]
Amitani, Haruka [1 ]
Inui, Akio [1 ]
机构
[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 8908520, Japan
关键词
Cachexia; Anorexia; Muscle wasting; Ghrelin; Melanocortin; LEUKEMIA INHIBITORY FACTOR; LEAN BODY-MASS; CANCER-RELATED ANOREXIA/CACHEXIA; PLACEBO-CONTROLLED TRIAL; PITUITARY-ADRENAL AXIS; CHRONIC KIDNEY-DISEASE; CELL LUNG-CANCER; SKELETAL-MUSCLE; DOUBLE-BLIND; ANOREXIA-CACHEXIA;
D O I
10.1016/j.biocel.2013.07.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Cachexia is characterized by anorexia, weakness, weight loss, and muscle wasting. Anorexia and muscle wasting are the key features of cachexia and they affect mortality, morbidity, and quality of life. Consistent studies have found that feeding-regulating peptides such as melanocortin, ghrelin, and leptin are related to muscle metabolism, and the balance of catabolism and anabolism in muscle is regulated in the hypothalamus, which also regulates appetite and energy expenditure. In cachexia, proinflammatory cytokines, such as TNF-alpha, IL-1, IL-6 and Angiotensin II induce muscle atrophy. The mechanism is suggested via upregulation of MuRF1 and MAFbx. In contrast, the orexigenic peptide, AgRP and ghrelin have the effect to decrease proinflammatory cytokines and increase body weight, food intake, and muscle mass. The understandings of the pathological mechanism of anorexia and muscle metabolism in view of the crosstalk between brain and muscle will open the new way for the management of cachexia. In this review, we describe recent experimental and clinical studies that have examined the regulation of food intake and muscle wasting in cachexia. This article is part of a Directed Issue entitled: Molecular basis of muscle wasting. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2179 / 2185
页数:7
相关论文
共 98 条
[1]
Cytokines in the pathogenesis of cancer cachexia [J].
Argilés, JM ;
Busquets, S ;
López-Soriano, FJ .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2003, 6 (04) :401-406
[2]
The potential of ghrelin in the treatment of cancer cachexia [J].
Argiles, Josep M. ;
Stemmler, Britta .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (01) :67-76
[3]
Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia [J].
Attaix, D ;
Combaret, L ;
Tilignac, T ;
Taillandier, D .
MOLECULAR BIOLOGY REPORTS, 1999, 26 (1-2) :77-82
[4]
Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx [J].
Balasubramaniam, Ambikaipakan ;
Joshi, Rashika ;
Su, Chunhua ;
Friend, Lou Ann ;
Sheriff, Sulaiman ;
Kagan, Richard J. ;
James, J. Howard .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2009, 296 (04) :R893-R901
[5]
Hypercatabolism and hypermetabolism in wasting states [J].
Baracos, VE .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2002, 5 (03) :237-239
[6]
Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation [J].
Barber, MD .
NUTRITION, 2001, 17 (09) :751-755
[7]
Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes [J].
Barton, BE .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (04) :737-752
[8]
STAT3 signalling is required for leptin regulation of energy balance but not reproduction [J].
Bates, SH ;
Stearns, WH ;
Dundon, TA ;
Schubert, M ;
Tso, AWK ;
Wang, YP ;
Banks, AS ;
Lavery, HJ ;
Haq, AK ;
Maratos-Flier, E ;
Neel, BG ;
Schwartz, MW ;
Myers, MG .
NATURE, 2003, 421 (6925) :856-859
[9]
A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer [J].
Bayliss, Trevor J. ;
Smith, Jeff T. ;
Schuster, Michael ;
Dragnev, Konstantin H. ;
Rigas, James R. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (12) :1663-1668
[10]
A randomized, double-blind, placebo-controlled trial of a β-hydroxyl β-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122) [J].
Berk, Lawrence ;
James, Jennifer ;
Schwartz, Anna ;
Hug, Eugen ;
Mahadevan, Anand ;
Samuels, Michael ;
Kachnic, Lisa .
SUPPORTIVE CARE IN CANCER, 2008, 16 (10) :1179-1188